Pacific Biosciences of California Inc (PACB)
NASDAQ
Quarter End | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 | 9 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 27.35M | 38.9M | 47.57M | 55.69M | 58.36M | 38.88M | 36.01M | 39.97M |
営業利益 | -84.86M | -91.25M | -73.18M | -82.49M | -87.55M | -81.36M | -175.85M | -64.01M |
税引前収入 | -84.38M | -88.02M | -69.83M | -77.58M | -82.74M | -78.18M | -173.32M | -60.73M |
純利益 | -84.38M | -88.02M | -69.83M | -66.87M | -82.02M | -78.18M | -173.32M | -60.73M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -78.52M | -84.39M | -64.25M | -73.99M | -111.97M | -74.6M | -169.78M | -64.09M |
EBITDA | -75.35M | -88.31M | -70.16M | -78.55M | -77.84M | -71.27M | -72.3M | -52.96M |
年末 2023年12月31日 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 90.71M | 93.47M | 78.63M | 90.89M | 78.89M | 130.51M | 128.3M | 200.52M |
営業利益 | -71.24M | -89.78M | -100.99M | -100.55M | -104.39M | -210.44M | -307.2M | -334.47M |
税引前収入 | -74.38M | -92.19M | -102.56M | -84.13M | 29.4M | -274.87M | -314.25M | -318.16M |
純利益 | -74.38M | -92.19M | -102.56M | -84.13M | 29.4M | -181.22M | -314.25M | -306.74M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | -0.803 | -0.793 | -0.683 | -0.549 | 0.153 | -0.82 | -1.387 | -1.147 |
EBIT | -71.14M | -89.27M | -100.14M | -81.52M | 29.67M | -262.34M | -299.56M | -334.58M |
EBITDA | -67.37M | -81.34M | -93.77M | -90.6M | -95.08M | -198.93M | -290.06M | -314.86M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約